TrademarkDir
PMI PRECISION MEDICINE IN CHRONIC INFLAMMATION
LIVE

Serial Number

79281699

Owner

Christian-Albrechts- Universität zu Kiel

Attorney

Timothy A. Bush,

Filing Date

Dec 11, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PMI PRECISION MEDICINE IN CHRONIC INFLAMMATION Trademark

Serial Number: 79281699 • Registration: 6854424

PMI PRECISION MEDICINE IN CHRONIC INFLAMMATION is a trademark filed by Christian-Albrechts- Universität zu Kiel on December 11, 2019. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Christian-Albrechts- Universität zu Kiel (2 trademarks)

Christian-Albrechts-Platz 4
Kiel 24118 , DE

Entity Type: 03

Trademark Details

Filing Date

December 11, 2019

Registration Date

September 27, 2022

Published for Opposition

April 12, 2022

Goods & Services

Medical consultation services in the field of inflammatory medicine; medical services, namely, providing physical and medical examinations; therapeutic and medical care for individuals suffering from inflammatory diseases or injuries, namely, therapeutic administration of drugs, therapeutic massages, surgery and therapeutic psychological counseling; hospital services; nursing services; all the aforesaid services relating to medical and clinical research and services in the field of inflammatory medicine

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 18, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 18, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 21, 2022 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 11, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 12, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Apr 10, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 3, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 3, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 3, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 3, 2022 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 19, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 1, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 1, 2021 OPNR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Jul 12, 2021 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Jul 12, 2021 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jul 12, 2021 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 21, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Mar 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Mar 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2021 CRFA
ASSIGNED TO LIE
Jan 25, 2021 ALIE
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2020 NREP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2020 TROA
REFUSAL PROCESSED BY IB
May 15, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 7, 2020 MAFR
ASSIGNED TO EXAMINER
Apr 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 26, 2020 REPR

Related Trademarks

More from this Owner

INFLAMMATION AT INTERFACES logo

INFLAMMATION AT INTERFACES

INFLAMMATION AT INTERFACES logo

INFLAMMATION AT INTERFACES

INFLAMMATION AT INTERFACES logo

INFLAMMATION AT INTERFACES